e-learning
resources
London 2016
Tuesday, 06.09.2016
IPF clinical
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Development of a national patient charter for idiopathic pulmonary fibrosis
Nicola Cassidy (Dublin, Ireland), Nicola Cassidy, Liam Galvin, Denise Dunne, Jim Egan
Source:
International Congress 2016 – IPF clinical
Session:
IPF clinical
Session type:
Oral Presentation
Number:
4569
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Nicola Cassidy (Dublin, Ireland), Nicola Cassidy, Liam Galvin, Denise Dunne, Jim Egan. Development of a national patient charter for idiopathic pulmonary fibrosis. Eur Respir J 2016; 48: Suppl. 60, 4569
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Related content which might interest you:
Health status & impact of living with idiopathic pulmonary fibrosis (IPF): UK & Ireland Delphi survey
Source: International Congress 2016 – IPF clinical
Year: 2016
The development of a measure to better understand patient experiences with pirfenidone and nintedanib for the treatment of idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Quality of life measures in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Health care system resource utilisation in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
IPF Care, a support program for patients with idiopathic pulmonary fibrosis in the UK
Source: International Congress 2015 – Latest insights into chronic care
Year: 2015
Quality of life of idiopathic pulmonary fibrosis patients
Source: Eur Respir J 2001; 17: 954-961
Year: 2001
The burden of idiopathic pulmonary fibrosis reported by patients and carers in Ireland
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
LATE-BREAKING ABSTRACT: Health-related quality of life of patients with idiopathic pulmonary fibrosis
Source: International Congress 2014 – Management of COPD in primary care
Year: 2014
The lived experience of idiopatic pulmonary fibrosis: A qualitative study
Source: International Congress 2016 – Respiratory nursing research: opening new perspectives on patient experiences
Year: 2016
Quality of life of patients with idiopathic pulmonary fibrosis (IPF) - What can the Australian IPF registry tell us?
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015
Value of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis
Source: International Congress 2014 – Best posters in physical activity, exercise testing and muscles
Year: 2014
Development of the interstitial lung disease multidiciplinary team meeting 2005-2013
Source: International Congress 2015 – Kaleidoscope of nursing research
Year: 2015
European idiopathic pulmonary fibrosis Patient Charter: a missed opportunity
Source: Eur Respir J 2016; 48: 283-284
Year: 2016
European idiopathic pulmonary fibrosis Patient Charter: a missed opportunity
Source: Eur Respir J 2016; 48: 282-283
Year: 2016
Benefits of pulmonary rehabilitation and predictor of changes in exercise capacity for idiopathic pulmonary fibrosis
Source: International Congress 2014 – Latest insights in pulmonary rehabilitation
Year: 2014
A supportive care decision aid tool for idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
Quality of life in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 30s
Year: 2005
Quality of life of idiopathic pulmonary fibrosis patients
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017
The physical and psychological needs of patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Sleep quality among patients with idiopathic pulmonary fibrosis
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept